Updated on 21 September 2026
SnoreFree Health App - effective & smart therapy against snoring & OSA (obstructive sleep apnea)
CEO at SnoreFree Health App
Vienna, Austria
About
SnoreFree is an MDR-certified Class I medical device and lifestyle app that provides a non-invasive, side-effect-free digital therapeutic for primary snoring & obstructive sleep apnea (OSA). Built on scientifically proven logopedic & myofunctional principles, the platform trains upper airway muscles to treat the root causes of snoring without invasive surgeries, mouthpieces, or CPAP machines.
Key Value Pillars & Product Features:
Clinical Precision & Efficacy: Delivers up to 80% therapy efficacy through structured, personalised daily training plan. Interim data from an ongoing clinical trial (n=172 diagnosed OSAS patients) demonstrates statistically significant reductions in daytime sleepiness and sleep-related depression, along with overall sleep quality improvements.
Next-Gen Tech Stack & User Experience: Built on Kotlin Multiplatform with a brand-new UI/UX, localized in 5 languages, and enhanced by high-engagement features. An AI-powered sleep monitoring system and automated personalized anti-snoring coach are currently in active development.
Enterprise-Grade Security & Compliance: Engineered to the highest data protection standards, including ISO 27001 certification, full GDPR compliance, alignment with BSI TR-03161 standards.
Dual Monetization & Market Access Strategy:
-
Global B2C: Accessible worldwide on iOS & Android via a freemium model transitioning into recurring monthly & annual subscriptions.
-
B2B / Reimbursement Pathway: Application submitted to the BfArM for German DiGA (Health App on prescription) approval, positioning SnoreFree as a fully reimbursable, measurable tool for payers and providers to lower healthcare costs and mitigate long-term cardiovascular risks.
Looking for
- Distribution Partner
Applies to
- Biotech and Lifescience
- Medtech
Organisation
Similar opportunities
Service
Cost-Effectiveness Analysis (HTA) for AT Entering Japan
Tomofumi Fukamiya
CEO at The Elements, Inc.
Tokyo, Japan
Investment
Thyra Imaging – The Non-Invasive Neuroinflammation Imaging Platform
- Startup
- Healthcare
Elisabeth Brunner
CEO / Co-Founder at Thyra Imaging
Vienna, Austria
Product
Redgevity Master: full-body light system for spas, hotels, ryokan and longevity studios
- Medtech
- Importer
- Distribution Partner
- Biotech and Lifescience
Thomas Lechner
Co-Founder & CTO at Luminous Labs FlexCo
Graz, Austria